Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.
Fraley, M.E., Garbaccio, R.M., Arrington, K.L., Hoffman, W.F., Tasber, E.S., Coleman, P.J., Buser, C.A., Walsh, E.S., Hamilton, K., Fernandes, C., Schaber, M.D., Lobell, R.B., Tao, W., South, V.J., Yan, Y., Kuo, L.C., Prueksaritanont, T., Shu, C., Torrent, M., Heimbrook, D.C., Kohl, N.E., Huber, H.E., Hartman, G.D.(2006) Bioorg Med Chem Lett 16: 1775-1779
- PubMed: 16439123 
- DOI: https://doi.org/10.1016/j.bmcl.2006.01.030
- Primary Citation of Related Structures:  
2FKY, 2FL2, 2FL6 - PubMed Abstract: 
The evolution of 2,4-diaryl-2,5-dihydropyrroles as inhibitors of KSP is described. Introduction of basic amide and urea moieties to the dihydropyrrole nucleus enhanced potency and aqueous solubility, simultaneously, and provided compounds that caused mitotic arrest of A2780 human ovarian carcinoma cells with EC(50)s<10nM. Ancillary hERG activity was evaluated for this series of inhibitors.
Organizational Affiliation: 
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. mark_fraley@merck.com